Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
47.74
+1.52 (3.29%)
At close: Sep 26, 2025, 4:00 PM EDT
47.67
-0.07 (-0.15%)
After-hours: Sep 26, 2025, 7:56 PM EDT
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of $3.82 billion as of September 26, 2025. Its market cap has increased by 114.68% in one year.
Market Cap
3.82B
Enterprise Value
2.77B
1-Year Change
114.68%
Ranking
Category
Stock Price
$47.74
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $495.47M to $3.82B, an increase of 670.72%. That is a compound annual growth rate of 38.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 3.82B | 96.66% |
| Dec 31, 2024 | 1.94B | 49.28% |
| Dec 29, 2023 | 1.30B | -49.24% |
| Dec 30, 2022 | 2.56B | 247.29% |
| Dec 31, 2021 | 737.89M | -17.63% |
| Dec 31, 2020 | 895.82M | 41.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |